OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC
Yiyi Huang, Yi-Fung Chau, Hua Bai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14521-14521
Open Access | Times Cited: 7
Yiyi Huang, Yi-Fung Chau, Hua Bai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14521-14521
Open Access | Times Cited: 7
Showing 7 citing articles:
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center
João Queirós Coelho, Raquel Romão, Maria João Sousa, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 1113-1128
Open Access | Times Cited: 1
João Queirós Coelho, Raquel Romão, Maria João Sousa, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 1113-1128
Open Access | Times Cited: 1
Development of Ex Vivo Analysis for Examining Cell Composition, Immunological Landscape, Tumor and Immune Related Markers in Non-small Cell Lung Cancer
Elena Ufimtseva, Margarita S. Gileva, Ruslan V. Kostenko, et al.
(2024)
Open Access | Times Cited: 1
Elena Ufimtseva, Margarita S. Gileva, Ruslan V. Kostenko, et al.
(2024)
Open Access | Times Cited: 1
Efficacy and safety of combining radiotherapy with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a real-world study
Guanli Yang, Zhen Zhou, Chengxin Liu
Immunopharmacology and Immunotoxicology (2024) Vol. 46, Iss. 6, pp. 861-871
Open Access
Guanli Yang, Zhen Zhou, Chengxin Liu
Immunopharmacology and Immunotoxicology (2024) Vol. 46, Iss. 6, pp. 861-871
Open Access
Biomarkers for immunotherapy resistance in non-small cell lung cancer
Catriona Rother, Thomas John, Annie Wong
Frontiers in Oncology (2024) Vol. 14
Open Access
Catriona Rother, Thomas John, Annie Wong
Frontiers in Oncology (2024) Vol. 14
Open Access
Development of Ex Vivo Analysis for Examining Cell Composition, Immunological Landscape, Tumor and Immune Related Markers in Non-Small-Cell Lung Cancer
Elena Ufimtseva, Margarita S. Gileva, Ruslan V. Kostenko, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2886-2886
Open Access
Elena Ufimtseva, Margarita S. Gileva, Ruslan V. Kostenko, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2886-2886
Open Access
M6A and lactylation modification-related signature predicts prognosis and immunotherapy response in hepatocellular carcinoma
Ren Hui-li, Jianhua Liu, Shaohui Zhang
(2024)
Closed Access
Ren Hui-li, Jianhua Liu, Shaohui Zhang
(2024)
Closed Access
Expression of extracellular HSP90α in pre- and post-treatment samples of driver-gene-negative non-small cell lung cancer
Zhaorong Feng, Haizhou Liu, Jinglei Huang, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113792-113792
Open Access
Zhaorong Feng, Haizhou Liu, Jinglei Huang, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113792-113792
Open Access
